首页> 外文期刊>The Journal of Nuclear Medicine >Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom (see comments)
【24h】

Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom (see comments)

机译:用99mTc-bitistatin(一种来自蛇毒的血小板结合多肽)对肺栓子和深静脉血栓成像(见注释)

获取原文
获取原文并翻译 | 示例
           

摘要

An imaging test that could locate both pulmonary emboli (PE) and their source, active deep venous thrombi (DVT), would be valuable in patient management. Bitistatin, an 83-amino-acid polypeptide isolated from Bitis arietans venom, binds avidly to the glycoprotein IIb/IIIa receptor on platelets. The goal of this study was to label bitistatin with 99mTc and assess its potential for imaging thrombi and emboli in vivo. METHODS: Molecular modeling of bitistatin indicated that its primary amines are located on the opposite side of the molecule from the receptor-binding domain. The primary amines were reacted with succinimidyl-4-hydrazino nicotinate hydrochloride to place 2.4 hydrazino nicotinate (Hn) chelating groups per peptide molecule. Hn-bitistatin was labeled by incubation with 99mTc-glucoheptonate to 96 TBq/mmol and then tested for binding to platelets in vitro and for imaging of 24-h-old DVT and PE in a canine model used previously for other thrombus tracers. RESULTS: 99mTc-Hn-bitistatin bound to stimulated platelets with a dissociation constant (Kd) = 32 nmol/L, similar to that of 125I-bitistatin (Kd = 41 nmol/L). In vivo, focal uptake was observed in planar images as early as 30 min (DVT) and 60 min (PE) after injection. Lesion uptake of 99mTc-Hn-bitistatin at 4 h after injection was calculated in terms of percentage injected dose per gram (%ID/g) of tissue and averaged 0.89 %ID/g PE and 0.79 %ID/g DVT. Lesion-to-background ratios averaged 34:1 (PE-to-lung), 18:1 (DVT-to-blood), and 284:1 (DVT-to-muscle). These values were not significantly different from iodinated bitistatin, but uptakes were higher than other tracers tested in the same model. CONCLUSION: 99mTc-Hn-bitistatin retains the functional activity of the iodinated peptide, has higher DVT and PE uptakes than other thrombus tracers in this standardized model, and has target-to-background characteristics suitable for imaging both PE and DVT in a single test.
机译:可以定位肺栓塞(PE)及其源头,活动性深静脉血栓(DVT)的影像学检查对患者管理很有价值。 Bitistatin是一种分离自Arietans毒液的83个氨基酸的多肽,与血小板上的糖蛋白IIb / IIIa受体狂热结合。这项研究的目的是用99mTc标记比斯汀,并评估其在体内成像血栓和栓子的潜力。方法:bitistatin的分子模型表明它的伯胺位于分子与受体结合域相反的一侧。伯胺与琥珀酰亚胺-4-肼基烟酸酯盐酸盐反应,以使每个肽分子具有2.4个肼基烟酸酯(Hn)螯合基团。 Hn-bitistatin通过与99mTc-葡庚糖酸盐孵育至96 TBq / mmol进行标记,然后在先前用于其他血栓示踪剂的犬模型中测试其与血小板的结合以及对24小时DVT和PE的成像。结果:99mTc-Hn-比斯他汀与刺激的血小板结合,其解离常数(Kd)= 32 nmol / L,与125I-比斯他汀(Kd = 41 nmol / L)相似。在体内,早在注射后30分钟(DVT)和60分钟(PE)即可在平面图像中观察到局部摄取。根据每克组织注射剂量的百分比(%ID / g)计算注射后4 h的99mTc-Hn-bitistatin的病变吸收率,平均为0.89%ID / g PE和0.79%ID / g DVT。病变与背景的比例平均为34:1(PE与肺),18:1(DVT与血液)和284:1(DVT与肌肉)。这些值与碘化比斯他汀没有显着差异,但摄取量高于在同一模型中测试的其他示踪剂。结论:在此标准化模型中,99mTc-Hn-bitistatin保留了碘化肽的功能活性,具有比其他血栓示踪剂更高的DVT和PE摄取,并且具有适合在一次测试中对PE和DVT成像的靶点到背景特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号